| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥21.7B | ¥33.2B | -34.5% |
| Operating Income | ¥-8.6B | ¥-8.2B | -5.0% |
| Ordinary Income | ¥-8.3B | ¥-8.6B | +3.5% |
| Net Income | ¥-11.5B | ¥-8.8B | -30.5% |
| ROE | -150.3% | -99.2% | - |
FY2025 results show severe financial deterioration with revenue of ¥21.7B (YoY -34.5%), operating loss of ¥8.6B (YoY -5.0% deterioration), ordinary loss of ¥8.3B (YoY +3.5% improvement), and net loss of ¥11.5B (YoY -30.5% deterioration). The company recorded negative gross profit of ¥3.2B with a gross margin of -14.9%, marking a fundamental breakdown in business profitability. Operating cash flow remained deeply negative at ¥8.7B, though improving 9.6% YoY. Free cash flow reached ¥9.8B negative. The company relied on financing cash flow of ¥10.2B to maintain cash position at ¥8.8B. Total assets declined to ¥15.9B with equity of ¥7.7B, resulting in an equity ratio of 48.1%. Basic EPS deteriorated to ¥-44.19 from ¥-36.09 prior year.
Revenue declined ¥11.5B or 34.5% YoY from ¥33.2B to ¥21.7B, representing a severe contraction in top-line performance. Geographic revenue disclosure indicates that domestic Japan sales exceed 90% of total revenue, suggesting limited international diversification and concentrated exposure to the domestic market. The revenue decline appears structural rather than cyclical, driven by underlying business model challenges in the company's core operations.
Cost of sales reached ¥24.9B against revenue of ¥21.7B, resulting in negative gross profit of ¥3.2B and a gross margin of -14.9%. This represents a critical profitability crisis where the company is selling products below their direct production costs. The cost structure indicates either severe pricing pressure, inventory valuation issues, or fundamental misalignment between revenue recognition and cost allocation. Selling, general and administrative expenses totaled ¥5.3B, representing 24.6% of revenue. While SG&A in absolute terms may have been managed, the fixed cost burden became disproportionately heavy relative to the shrinking revenue base, amplifying operating leverage in the negative direction.
Operating loss reached ¥8.6B compared to ¥8.2B in the prior year, showing a 5.0% deterioration despite the company likely implementing cost reduction measures. The operating margin of -39.5% reflects catastrophic operational efficiency. Non-operating items provided slight relief with net non-operating income of ¥0.2B, primarily comprising interest income of ¥0.1B offset by interest expense of ¥0.4B. Ordinary loss improved marginally to ¥8.3B from ¥8.6B prior year, representing a 3.5% improvement driven by the non-operating account.
The gap between ordinary loss of ¥8.3B and net loss of ¥11.5B amounts to ¥3.2B, explained by extraordinary losses of ¥3.2B including litigation settlement of ¥0.5B as a non-recurring factor. Income tax expense was minimal at approximately ¥0.0B due to the loss position. The ¥3.2B extraordinary loss represents a material 14.7% of revenue and significantly contributed to the 30.5% deterioration in net income YoY.
This represents a revenue down, profit down pattern with severe deterioration across all profitability metrics. The negative gross margin indicates fundamental business model stress requiring immediate structural intervention.
[Profitability] ROE of -150.3% reflects severe capital destruction driven by net profit margin of -53.0%, asset turnover of 1.362, and financial leverage of 2.08 in DuPont decomposition. Operating margin deteriorated to -39.5%, indicating the company consumes ¥0.40 in operating costs for every ¥1.00 of revenue before recovering any direct product costs. The negative gross margin of -14.9% represents a critical profitability threshold breach. [Cash Quality] Cash and deposits stood at ¥8.8B, providing coverage of 2.94x against short-term debt. Operating cash flow to net income ratio of 0.76 falls below the 0.8 quality threshold, signaling that reported losses are only partially reflected in cash consumption. [Investment Efficiency] Asset turnover of 1.362 indicates the company generates ¥1.36 in revenue per ¥1.00 of assets, representing relatively efficient asset utilization despite the profitability crisis. [Financial Health] Equity ratio of 48.1% provides moderate financial cushion with total equity of ¥7.7B against total assets of ¥15.9B. Current ratio of 160.5% indicates adequate short-term liquidity with current assets of ¥13.2B covering current liabilities of ¥8.2B. Debt-to-equity ratio of 0.28 shows conservative leverage. However, 100% of debt is short-term with ¥0.3B in current bonds, creating refinancing pressure. Interest coverage is deeply negative at -24x, indicating no earnings available to service interest expense of ¥0.4B.
Operating cash flow of ¥8.7B negative represents 0.76x of net loss of ¥11.5B, indicating that reported losses are partially offset by non-cash charges including the ¥3.2B extraordinary loss. Cash flow from operating activities before working capital changes was ¥8.4B negative. Working capital movements showed trade receivables decreasing by ¥0.6B, contributing positive cash effect as collections accelerated relative to declining sales. Trade payables decreased by ¥0.7B, consuming cash as the company reduced supplier credit utilization. Contract liabilities decreased by ¥0.7B, indicating advance customer payments declined and suggesting weakening forward business momentum. Interest paid of ¥0.3B represented a direct cash drain on operating activities. Investing cash flow of ¥1.1B negative was driven primarily by minimal capital expenditure of ¥0.03B, with the remaining ¥1.1B potentially allocated to other investment activities. Financing cash flow of ¥10.2B positive provided critical liquidity, likely through debt issuance or equity capital raising to offset the combined ¥9.8B negative free cash flow. The company's survival depends on continued access to external financing as internal cash generation remains severely impaired.
Ordinary loss of ¥8.3B versus operating loss of ¥8.6B reflects net non-operating contribution of approximately ¥0.2B. Non-operating income of ¥0.7B comprises primarily interest income of ¥0.1B and other miscellaneous items. Non-operating expenses of ¥0.4B are dominated by interest expense of ¥0.4B related to debt servicing. Net non-operating items represent 1.1% of revenue, providing minimal impact relative to the core operating losses. Extraordinary loss of ¥3.2B including litigation settlement of ¥0.5B represents 14.7% of revenue and materially impacted reported net income, though these are non-recurring factors. Operating cash flow of ¥8.7B negative compared to net loss of ¥11.5B suggests that approximately ¥2.8B of reported losses were non-cash in nature, primarily the extraordinary charges. However, the operating cash flow remaining deeply negative indicates underlying business operations are consuming cash at an unsustainable rate. The operating CF to net income ratio of 0.76 raises earnings quality concerns. Accruals analysis shows working capital consumed net cash as payables declined faster than receivables. The combination of negative gross margins, negative operating cash flow, and dependence on financing activities signals severely compromised earnings quality requiring immediate operational restructuring.
Revenue sustainability risk represents the primary threat, with top-line declining 34.5% YoY to ¥21.7B and concentrated 90% in the domestic Japan market. The magnitude and velocity of revenue contraction suggests structural market share loss or product life-cycle deterioration rather than temporary cyclical weakness. Without disclosed segment details, the concentration risk within specific product lines or customer relationships cannot be quantified but likely remains high. Gross margin inversion risk poses an existential threat with gross profit of ¥3.2B negative and gross margin of -14.9%, indicating the company sells products below direct production costs. This pricing structure is economically unsustainable and suggests either inventory write-downs, unfavorable contract terms, or fundamental cost structure misalignment. Operating leverage amplifies losses as ¥5.3B in SG&A expenses represent 24.6% of the declining revenue base, creating a fixed cost burden that accelerates loss accumulation. Liquidity and refinancing risk materializes through 100% short-term debt composition totaling ¥3.0B with current portion of bonds at ¥0.3B. While cash of ¥8.8B provides 2.94x coverage, operating cash flow of ¥8.7B negative annually would deplete this cushion within approximately one year absent external financing. The company raised ¥10.2B through financing activities this period, but sustained access to capital markets or lender support cannot be assured given the deteriorating financial performance. Interest coverage of -24x quantifies the inability to service debt from operations.
[Industry Position] (Reference - Proprietary Analysis) The company's financial metrics significantly underperform typical industry standards for sustainable operations. Operating margin of -39.5% compares unfavorably to positive mid-single digit to low-teen operating margins typical in software and digital content industries. ROE of -150.3% represents extreme capital destruction versus industry median ROE typically ranging 5% to 15% for established players. The equity ratio of 48.1% appears reasonable relative to industry leverage practices, though the sustainability of this capital base is threatened by ongoing losses. The company's negative gross margin of -14.9% represents an outlier position, as viable industry participants maintain positive gross margins typically ranging 40% to 70% in digital content and software businesses. Revenue decline of 34.5% YoY substantially exceeds normal industry volatility, suggesting company-specific distress rather than sector-wide contraction. Cash generation capability, as measured by operating cash flow of ¥8.7B negative, contrasts sharply with healthy industry peers that convert 10% to 20% of revenue into operating cash flow. The company's current financial trajectory appears unsustainable without significant operational restructuring and strategic repositioning.
Fundamental business model distress is evidenced by negative gross margin of -14.9%, indicating revenue generated fails to cover direct production costs by ¥3.2B. This represents a critical threshold breach requiring immediate intervention, as no amount of SG&A reduction can restore profitability without addressing the gross margin inversion. The magnitude of this issue, combined with 34.5% revenue decline, signals potential product obsolescence, severe competitive displacement, or fundamental pricing/cost structure misalignment. Operating cash flow deterioration to ¥8.7B negative consumption rate, when compared to cash reserves of ¥8.8B, implies a runway of approximately 12 months before liquidity crisis absent external financing. The company raised ¥10.2B through financing activities this period, demonstrating current access to capital markets, but this dependence on external funding is unsustainable and likely leads to significant shareholder dilution. The accumulated retained earnings deficit of ¥90.4B represents sustained historical losses that have eroded the capital base. Structural reform urgency is highlighted by the combination of deteriorating unit economics (negative gross margin), operational inefficiency (39.5% operating margin negative), and cash burn requiring immediate strategic action including potential business model pivot, dramatic cost restructuring, asset rationalization, or strategic alternatives to preserve remaining enterprise value.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.